Additionally, deletion of NEMO leads to rarefaction of brain microvessels50 and increased vascular permeability in the brain is observed in COVID-19 patients with neurological symptoms51, which resembles those of incontinentia pigmenti52. This evidence concerns the gene IKBKG and COVID-19.